Invention Grant
- Patent Title: Treatment of cancer with a novel anti-IL13 monoclonal antibody
- Patent Title (中): 用新型抗IL13单克隆抗体治疗癌症
-
Application No.: US10583926Application Date: 2004-12-23
-
Publication No.: US07674459B2Publication Date: 2010-03-09
- Inventor: Sek Chung Fung , Matthew Moyle
- Applicant: Sek Chung Fung , Matthew Moyle
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Jones Day
- International Application: PCT/US2004/043541 WO 20041223
- International Announcement: WO2005/062972 WO 20050714
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention relates to the treatment of IL13 dependent neoplastic disorders comprising the administration of novel anti-IL13 antibodies, The invention also includes diagnosing such tumors or cancer using the antibodies of the present invention to detect overexpression of IL13 in the patient.
Public/Granted literature
- US20080008648A1 Treatment of Cancer With a Novel Anti-Il13 Monoclonal Antibody Public/Granted day:2008-01-10
Information query
